1. Home
  2. AIHS vs TCRT Comparison

AIHS vs TCRT Comparison

Compare AIHS & TCRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

AIHS

Senmiao Technology Limited

N/A

Current Price

$1.17

Market Cap

5.7M

Sector

Finance

ML Signal

N/A

Logo Alaunos Therapeutics Inc.

TCRT

Alaunos Therapeutics Inc.

HOLD

Current Price

$2.63

Market Cap

6.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AIHS
TCRT
Founded
2014
1998
Country
China
United States
Employees
N/A
N/A
Industry
Finance: Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.7M
6.7M
IPO Year
2017
2025

Fundamental Metrics

Financial Performance
Metric
AIHS
TCRT
Price
$1.17
$2.63
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
14.0K
12.3K
Earning Date
02-13-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
14.63
24.66
EPS
N/A
N/A
Revenue
$3,389,072.00
$15,900,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.25
$1.67
52 Week High
$8.26
$5.48

Technical Indicators

Market Signals
Indicator
AIHS
TCRT
Relative Strength Index (RSI) 44.09 38.58
Support Level $1.10 $2.59
Resistance Level $1.28 $2.84
Average True Range (ATR) 0.10 0.14
MACD -0.01 -0.01
Stochastic Oscillator 24.21 39.52

Price Performance

Historical Comparison
AIHS
TCRT

About AIHS Senmiao Technology Limited

Senmiao Technology Ltd is a holding company. Along with its subsidiaries, it is engaged in facilitating automobile transactions and offering related services. The group's business activities include providing car rental services to individual customers with lease term no more than twelve months; leasing and servicing of new energy vehicles; offering services to automobile purchasers throughout the purchase process; providing management and related services to Partner Platforms and other companies; automobile financing; and providing other related supporting services to customers. The majority of the group's revenue is generated from its automobile rental business.

About TCRT Alaunos Therapeutics Inc.

Alaunos Therapeutics Inc is a preclinical stage obesity and metabolic health drug development company that is aiming to develop a small molecule-based drug to treat obesity and other metabolic disorders that have a differentiated profile relative to currently marketed and in development oral and injectable products. The company focuses on evaluating the impact of ALN1001, its primary program, and its derivatives on lipid deposition and gene expression. It aims to develop an oral obesity compound that addresses many of the shortcomings of injectable GLP-1 receptor agonists including preserving lean muscle mass.

Share on Social Networks: